![Elena Feinstein](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Elena Feinstein
Chief Tech/Sci/R&D Officer at Quark Pharmaceuticals, Inc.
Elena Feinstein active positions
Companies | Position | Start | End |
---|---|---|---|
Quark Pharmaceuticals, Inc.
![]() Quark Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Quark Pharmaceuticals, Inc. discovers and develops novel RNAi-based therapeutics. The firm’s products include QPI-1002 and QPI-1007 is being developed as a neuroprotective agent for the treatment of optic neuropathies that result in the death of retinal ganglion cells. The company was founded by Daniel Zurr, David M. Fineman and J. Gregory Swendsen in December 1993 and is headquartered in Fremont, CA. | Chief Tech/Sci/R&D Officer | 1997-12-31 | - |
Career history of Elena Feinstein
Training of Elena Feinstein
Moscow University | Doctorate Degree |
Weizmann Institute of Science | Doctorate Degree |
Statistics
International
United States | 2 |
Russia | 2 |
Israel | 2 |
Operational
Doctorate Degree | 2 |
Chief Tech/Sci/R&D Officer | 1 |
Sectoral
Consumer Services | 3 |
Health Technology | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Private companies | 1 |
---|---|
Quark Pharmaceuticals, Inc.
![]() Quark Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Quark Pharmaceuticals, Inc. discovers and develops novel RNAi-based therapeutics. The firm’s products include QPI-1002 and QPI-1007 is being developed as a neuroprotective agent for the treatment of optic neuropathies that result in the death of retinal ganglion cells. The company was founded by Daniel Zurr, David M. Fineman and J. Gregory Swendsen in December 1993 and is headquartered in Fremont, CA. | Health Technology |
- Stock Market
- Insiders
- Elena Feinstein
- Experience